Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1681)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 7, 2024 (publication date) through Jan 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lowell JA, Farber MJ, Sultan K. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease. World J Gastroenterol 2024; 30(25): 3182-3184 [PMID: 39006384 DOI: 10.3748/wjg.v30.i25.3182] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i25/3182.htm |
| Number | Citing Articles |
| 1 |
Wen-Ting Xie, Hui Yang, Lan Bai, Feng-Fei Wu. New perspectives and prospects for the next generation of combination therapy in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(5): 99462 doi: 10.3748/wjg.v31.i5.99462
|
| 2 |
Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
|
| 3 |
Zi-Ning Zhang, Li-Xuan Sang. Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it. World Journal of Gastroenterology 2024; 30(36): 4025-4030 doi: 10.3748/wjg.v30.i36.4025
|